Real-world use of ceftolozane/tazobactam: a systematic literature review.

Antimicrob Resist Infect Control · 2021 · PMC8027296 · PMID 33832545

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Results were comparable with Pogue et al.—patients treated with C/T had a numerically higher clinical cure rate and lower mortality rate than patients treated with aminoglycoside/polymyxin regimen, though this did not reach statistical significance [ 23 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.